High Content Phenotypic Profiling to Accelerate Drug Discovery
Tue, May 10, 2022 · 4:00 PM
ABOUT THIS WEBINAR
Drug discovery is a time-consuming and costly process. The majority of promising pre-clinical drug candidates eventually fail in clinical trials, due to poor efficacy or toxicity issues. Considerable efforts are therefore directed toward the development of more informative and predictive preclinical models and assays.
In this webinar, researchers from the University of Edinburgh demonstrate how they use advanced imaging approaches to advance drug discovery in diseases of unmet need. You will learn:
- How high content phenotypic screening approaches help to obtain a deeper understanding of target biology and drug mechanism of action.
- How this helps to accelerate drug discovery for diseases of unmet need.
Prof. Neil Carragher - Advancing high content phenotypic and pathway profiling to accelerate drug discovery across disease areas of unmet need
Dr. John Dawson - Application of multiparametric high content analysis across a panel of patient-derived glioblastoma cells
Dr. Richard Elliott - High content phenotypic screening across heterogeneous panels of cancer cell models